Halozyme Therapeutics Investors

Halozyme Therapeutics is a biotechnology company headquartered in San Diego, California, founded in 1998 The company specializes in the development of innovative therapies for the treatment of various medical conditions, leveraging its proprietary enzyme technology Halozyme has attracted significant investment, with funding exceeding hundreds of millions of dollars to support its research and development initiatives The firm is recognized for its strategic partnerships with major pharmaceutical companies, enhancing its market presence and accelerating the commercialization of its products With a focus on improving patient outcomes, Halozyme continues to advance its pipeline of therapeutics in the biotechnology sector

Employee Number: 101-250
Funding Status: IPO
Headquarters: USA
Technology: Cancer
Estimated Revenue: $10M to $50M
Founded Date: 1998
Investor Type: Investment Banks
Industry: FemTech